Table 1.
Correlation between clinicopathological characteristics and MMTV-like virus positivity
| Clinicopathological characteristics | MMTV-like virus positive (%) | MMTV-like virus negative (%) | p value |
|---|---|---|---|
| Age | |||
| ≤50 years | 3 (4) | 22 (30) | |
| >50 years | 8 (11) | 41 (55) | 0.74 |
| Total | 11 (15) | 63 (85) | |
| Nottingham histological grade | |||
| Grade | |||
| I | 4 (5.5) | 10 (14) | |
| II | 4 (5.5) | 36 (50) | 0.25 |
| III | 3 (4) | 15 (21) | |
| Total | 11 (15) | 61 (85) | |
| Tumor stage | |||
| Stage | |||
| Early stage (I–I) | 6 (13) | 33 (70) | |
| Advanced stage (III–IV) | 0 (0) | 8 (17) | 0.57 |
| Total | 6 (13) | 41 (87) | |
| ER status | |||
| ER+ | 9 (12) | 50 (70) | |
| ER– | 2 (3) | 11 (15) | 0.68 |
| Total | 11 (15) | 61 (85) | |
| PR status | |||
| PR+ | 7 (10) | 47 (65) | |
| PR– | 4 (5) | 14 (20) | 0.57 |
| Total | 11 (15) | 61 (85) | |
| HER-2 status | |||
| HER-2+ | 5 (7) | 11 (15) | |
| HER-2– | 6 (8) | 50 (70) | 0.06 |
| Total | 11 (15) | 61 (85) |
Comparison was made between presence/absence of HPV (HPV+/HPV−) and clinicopathological characteristics. * Indicates significant p values (p < 0.05).